MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient

Nephrol Dial Transplant. 2000 Jan;15(1):110-2. doi: 10.1093/ndt/15.1.110.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
  • Anuria / physiopathology
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacokinetics
  • Doxorubicin / administration & dosage
  • Doxorubicin / pharmacokinetics
  • Humans
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / physiology
  • Lymphatic Metastasis
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / pharmacokinetics
  • Recurrence
  • Urinary Bladder Neoplasms / complications*
  • Urinary Bladder Neoplasms / drug therapy*
  • Vinblastine / administration & dosage
  • Vinblastine / pharmacokinetics

Substances

  • Vinblastine
  • Doxorubicin
  • Cisplatin
  • Methotrexate

Supplementary concepts

  • M-VAC protocol